Condition: Breast Cancer · Sponsor: Umbria Bioengineering Technologies
This is a multicentric, single arm, prospective, stratified by breast density clinical investigation to confirm the ability of the microwave mammogram 'MammoWave' to detect breast lesions. MammoWave is a innovative medical device, class IIa marked CE, which uses microwaves instead of ionazing radiation (x-ray) for breast lesions. Specifically MammoWave employs a novel technique wich generates images by processing very low power (\<1mW) microwave. The MammoWave exam takes few minutes for breast and is performed with the patient lying in a confortable facing down position. MammoWave is safe to be used at any age, in any condition (pregnancy, specific illness and for unlimited number of times.
This description comes directly from the study's public registry record.
Gianluigi Tiberi · 0039 34900564302 · gianluigi@ubt-tech.com
Sabatino Tiberi · s.tiberi@ubt-tech.com
Always discuss trial participation with your own doctor first.
| IRCCS Policlinico San Martino | Genova, Genova, Italy | Recruiting |
| Ospedale San Giovanni Battista - USL Umbria 2 | Foligno, Perugia, Italy | Recruiting |
| Az. San. Univ. Giuliano Isontina (ASU GI) | Trieste, Italy | Recruiting |
| Hospital Universitario de Toledo | Toledo, Spain, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05300464